898. Adult RSV Prevention; Baby Steps to a Grown up Vaccine
Session: Symposium: Advances in RSV Prevention
Friday, October 5, 2018: 9:10 AM
Room: N 24
Ann R. Falsey, MD, Department of Medicine, Division of Infectious Diseases, University of Rochester, Rochester, NY

Dr Falsey is a Professor of Medicine at the University of Rochester School of Medicine. The focus of her research has been clinical and translational research in the field of respiratory viral infections in adults. Dr Falsey received her Bachelor of Science degree in Biology at Providence College and Doctorate in Medicine at Vanderbilt University School of Medicine. She completed her residency in Internal Medicine at Strong Memorial Hospital at the University of Rochester and infectious disease fellowship at Yale University and the University of Rochester. Initially the focus of her research was defining the epidemiology and impact of respiratory syncytial virus in adult populations. More recently, Dr Falsey has broadened her research to include numerous viral respiratory pathogens including influenza, coronaviruses, parainfluenza viruses and human metapneumovirus. She has conducted numerous adult surveillance and vaccine studies in a variety of settings including ambulatory older adult clinics, nursing homes and senior daycare centers. She has extensive experience in the development and performance of diagnostic and serologic assays for influenza and other respiratory viruses including cell culture, RT-PCR, EIA and neutralization assays. She is a member of the steering committee for the Global Influenza Initiative, the Infectious Diseases Society of America and the American Virology Society. Dr Falsey has published over 200 peer reviewed articles, reviews, book chapters and abstracts. She currently serves as the Interim Chief of Infectious Disease Division and the Co-Director for the National Institute of Allergy and Infectious Diseases Respiratory Pathogen Research Center at the University of Rochester.


Disclosures:

A. R. Falsey, sanofi pasteur: Consultant and Grant Investigator , Consulting fee and Research grant . Gilead: Consultant , Consulting fee . Merck Sharpe and Dome: Investigator , Grant recipient . Janssen Pharmacueticals: Investigator , Grant recipient . Pfizer: Consultant , Research grant . Novavax: Consultant , none .

See more of: Advances in RSV Prevention
See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.